Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase IIIC Inhibitor Antibiotics

Go back to Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase IIIC Inhibitor Antibiotics
(NASDAQ: ACXP) Delayed: 1.15 --0 (-0%)
Previous Close $1.15    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.15    P/E N/A 
Day Low $1.15    EPS $ 
Volume 1